DNMT3A and myelodysplastic syndrome: Altogether, these data support the critical involvement of DNMT3A in regulating HSC differentiation [11] and suggest that the loss of de novo DNMT3A activity might impair the differentiation potential of HSC, providing a possible explanation for how DNMT3A mutations can contribute to AML and myelodysplastic syndrome (MDS) pathogenesis.